Rezolute, Inc.

NASDAQ:RZLT

Biotechnology

Healthcare
$4.25 +6.16%

+$0.30 today

Market cap
$411.10M
Beta
0.65
P/E (TTM)
-6.5
EPS (TTM)
-$0.78
52W Low $1.07High $11.46

Volume 2.93M

Average 2.03M

Returns on capital

Rezolute, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-45.9%

avg -186.0%

ROIC

-48.7%

avg 691.4%

ROA

-42.4%

avg -206.1%

Analysis

ROA is currently the strongest return metric at -42.4% versus its period average of -206.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Nevan Charles Elam

Founder, Chief Executive Officer & Acting Chairman of the BoardUSD 1.13M59——

Brian Kenneth Roberts

Chief Medical OfficerUSD 789.22K51293.85K0.31%

Daron G. Evans

Chief Financial & Business OfficerUSD 738.05K52——

Sunil Karnawat

Chief Commercial OfficerUSD 678.8K59——

Gopal Saha MBBS

Senior Vice President of Global Clinical Development————

Raj Agrawal

Vice President & Head of Ophthalmological Clinical Development————

Chris Milks

Vice President & Head of Finance————

Erin O'Boyle

Senior Vice President & Head of Clinical Operations————

Melissa Quinn

Senior Director of People and Culture————

Robyn Sweinhart

Vice President & Head of Quality————

Susan Stewart

Chief Regulatory Officer—65——

Davelyn Eaves Hood

Director and Head of Scientific & Patient Affairs————

Michael Covarrubias

Senior Vice President & Head of Program & Portfolio Management————

Michael R. Deperro

Senior VP & Head of Operations————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jul 2, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

10

$288,871.76

Sells

0

$0.00

Net Transaction Value

+$288,871.76

Net buying

Most Active

Evans Daron

5 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Mar 30, 26

Evans Daron

Direct

Buy$28.5K
Dec 16, 25

Hogenhuis Wladimir

Direct

Buy$9.5K
Dec 16, 25

ROBERTS BRIAN KENNETH

Direct

Buy$47.6K
Dec 15, 25

Evans Daron

Direct

Buy$70.6K
Dec 15, 25

Evans Daron

Indirect

Buy$4.5K
Dec 15, 25

Evans Daron

Indirect

Buy$4.5K
Dec 15, 25

Elam Nevan C

Direct

Buy$50.9K
Dec 15, 25

Karnawat Sunil Ratilal

Direct

Buy$160
Dec 15, 25

Karnawat Sunil Ratilal

Direct

Buy$19.4K
Dec 9, 25

Evans Daron

Direct

Buy$53.2K

Summary

Insiders reported 10 buys worth $288,871.76 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $288,871.76. Evans Daron was the most active insider with 5 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A2 analysts
RevenueN/AN/AN/A
N/A3 analysts
Net IncomeN/AN/AN/A
N/A3 analysts
EBITN/AN/AN/A
N/A3 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Rezolute, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about RZLT's management, answered from reported figures.

Who manages RZLT?

Rezolute, Inc. (RZLT) lists 14 active executives. The top listed executive is Brian Kenneth Roberts, Chief Medical Officer.

Are RZLT insiders buying or selling?

Recent insider activity shows net buying of $44.21M.